Loading clinical trials...
Loading clinical trials...
The primary aim is to show whether a reduction in tumor related mRNAs and a panel of selected miRNAS can be used to personalize enzalutamide therapy. Furthermore the aim is to explore the relation be...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Radboud University Medical Center
Collaborators
NCT07285694 · Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT06830850 · Metastatic Castration Resistant Prostate Cancer
NCT06517719 · Metastatic Castration Resistant Prostate Cancer
NCT06609005 · Advanced Metastatic Castration Resistant Prostate Cancer
NCT06894511 · Metastatic Castration Resistant Prostate Cancer (mCRPC)
Jeroen Bosch Ziekenhuis
's-Hertogenbosch
Radboud UMC
Nijmegen
Canisius Wilhelmina Ziekenhuis
Nijmegen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions